Landscape Design

By Bruna Paulsen

Autism spectrum disorder has been recently associated with hundreds  of different risk genes, yet it is unclear whether mutations in these  genes converge on a similar neurodevelopmental abnormality. In the  Arlotta Lab, we decided to investigate whether three autism-risk genes, SUV420H1, ARID1B, and CHD8, all with very broad hypothetical function, would converge on similar cellular phenotypes.

For that, we grew human brain organoids carrying mutations in each of  these genes over the course of several months. We found that all the  risk genes lead to asynchronous development of specific neurons,  although each one acted through unique underlying molecular mechanisms.  More specifically, among all the cells generated in these organoids,  just the GABAergic neurons and the deep-layer projection neurons were  consistently affected, pointing at selected cells that may be special  targets in this disorder.

Microscopy image of a brain organoid showing neuron precursors (magenta) and deep-layer projection neurons (green), which are one of the cell types affected by autism risk gene mutations. Credit: Paola Arlotta laboratory at Harvard University and Kwa
Microscopy image of a brain organoid showing neuron precursors (magenta) and deep-layer projection neurons (green), which are one of the cell types affected by autism risk gene mutations. Credit: Paola Arlotta laboratory at Harvard University and Kwanghun Chung laboratory at MIT.

Moreover, we also generated organoids using stem cells from different  donor individuals to test how changes in the organoids might be  impacted by an individual’s unique genetic background. We observed  consistent phenotypic abnormalities across cell lines; however, the  level of severity varied across individuals. This suggested that the  risk genes’ effects were fine-tuned by the rest of the donor genome.

Our findings that different autism-risk genes converge on a phenotype  of asynchronous neuronal development but mostly diverge at the level of  molecular targets suggests that a shared clinical pathology of these  genes may derive from higher-order processes of neuronal differentiation  and circuit wiring. These results encourage future investigation of  therapeutic approaches focusing on the modulation of shared  dysfunctional circuit properties in addition to shared molecular  pathways.

Bruna Paulsen, PhD, is a postdoctoral researcher working in the  lab of Paola Arlotta and one of the co-lead authors of this study along  with Silvia Velasco, Amanda Kedaigle and Martina Pigoni. The  authors thank all of their collaborators, noting this study would not  have been possible without the combined expertise of many individuals,  working together to tackle a complex problem from different angles.

This story also appeared on the Harvard Brain Science Initiative website and the Department of Stem Cell and Regenerative Biology.

Learn more in the original research article:
Autism genes converge on asynchronous development of shared neuron classes.
Paulsen B, Velasco S, Kedaigle AJ, Pigoni M, Quadrato G, Deo AJ, Adiconis X, Uzquiano A, Sartore R, Yang SM, Simmons SK, Symvoulidis P, Kim K, Tsafou K, Podury A, Abbate C, Tucewicz A, Smith SN, Albanese A, Barrett L, Sanjana NE, Shi X, Chung K, Lage K, Boyden ES, Regev A, Levin JZ, Arlotta P. Nature. 2022 Feb;602(7896):268-273.